Ankerite Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 13-12-2024
- Paid Up Capital ₹ 2.50 M
as on 13-12-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.29 M
as on 13-12-2024
- Revenue %
(FY 2020)
- Profit 88.75%
(FY 2020)
- Ebitda 96.72%
(FY 2020)
- Net Worth -14.73%
(FY 2020)
- Total Assets -26.03%
(FY 2020)
About Ankerite Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹0.29 M.
Kirti Kumar, Sunil Rohatgi, Reetika Rohatgi, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24232UP2006PTC031249
- Company No.
031249
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ankerite Pharmaceuticals Private Limited offer?
Ankerite Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Weight Gain Nutrition, Lean Mass Gainer, Fitness Supplements, Protein Supplements, Whey Protein, Workout Essential.
Who are the key members and board of directors at Ankerite Pharmaceuticals?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Rohatgi  | Director | 30-Sep-2009 | Current |
| Karan Kathuria | Director | 11-Jun-2020 | Current |
| Kirti Kumar | Director | 15-Dec-2008 | Current |
| Reetika Rohatgi | Director | 30-Sep-2009 | Current |
| Kiran Rohatgi | Director | 30-Sep-2009 | Current |
| Chandrabhan | Director | 11-Jun-2020 | Current |
Financial Performance of Ankerite Pharmaceuticals.
Ankerite Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 88.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ankerite Pharmaceuticals?
In 2019, Ankerite Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ankerite Health Care Private LimitedActive 28 years 4 monthsKirti Kumar, Sunil Rohatgi and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Feb 2018 | ₹0.29 M | Open |
How Many Employees Work at Ankerite Pharmaceuticals?
Unlock and access historical data on people associated with Ankerite Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ankerite Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ankerite Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
